These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 34599874)
21. High throughput screen identifies small molecule inhibitors specific for Mycobacterium tuberculosis phosphoserine phosphatase. Arora G; Tiwari P; Mandal RS; Gupta A; Sharma D; Saha S; Singh R J Biol Chem; 2014 Sep; 289(36):25149-65. PubMed ID: 25037224 [TBL] [Abstract][Full Text] [Related]
22. Targeting the messengers: Serine/threonine protein kinases as potential targets for antimycobacterial drug development. Khan MZ; Kaur P; Nandicoori VK IUBMB Life; 2018 Sep; 70(9):889-904. PubMed ID: 29934969 [TBL] [Abstract][Full Text] [Related]
23. Distinct substrate selectivity of a metabolic hydrolase from Mycobacterium tuberculosis. Lukowski JK; Savas CP; Gehring AM; McKary MG; Adkins CT; Lavis LD; Hoops GC; Johnson RJ Biochemistry; 2014 Dec; 53(47):7386-95. PubMed ID: 25354081 [TBL] [Abstract][Full Text] [Related]
24. Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis. Jackson M; McNeil MR; Brennan PJ Future Microbiol; 2013 Jul; 8(7):855-75. PubMed ID: 23841633 [TBL] [Abstract][Full Text] [Related]
25. Cell envelope lipids in the pathophysiology of Mycobacterium tuberculosis. Singh P; Rameshwaram NR; Ghosh S; Mukhopadhyay S Future Microbiol; 2018 May; 13():689-710. PubMed ID: 29771143 [TBL] [Abstract][Full Text] [Related]
26. Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus. Gupta R; Rodrigues Felix C; Akerman MP; Akerman KJ; Slabber CA; Wang W; Adams J; Shaw LN; Tse-Dinh YC; Munro OQ; Rohde KH Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483110 [No Abstract] [Full Text] [Related]
27. MmPPOX inhibits Mycobacterium tuberculosis lipolytic enzymes belonging to the hormone-sensitive lipase family and alters mycobacterial growth. Delorme V; Diomandé SV; Dedieu L; Cavalier JF; Carrière F; Kremer L; Leclaire J; Fotiadu F; Canaan S PLoS One; 2012; 7(9):e46493. PubMed ID: 23029536 [TBL] [Abstract][Full Text] [Related]
28. Characterization of a secretory hydrolase from Singh KH; Jha B; Dwivedy A; Choudhary E; N AG; Ashraf A; Arora D; Agarwal N; Biswal BK J Biol Chem; 2017 Jul; 292(27):11326-11335. PubMed ID: 28515317 [No Abstract] [Full Text] [Related]
29. An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis. Mori M; Sammartino JC; Costantino L; Gelain A; Meneghetti F; Villa S; Chiarelli LR Curr Top Med Chem; 2019; 19(9):646-661. PubMed ID: 30827246 [TBL] [Abstract][Full Text] [Related]
30. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance. Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862 [TBL] [Abstract][Full Text] [Related]
31. Identification of residues important for M. tuberculosis MmpL11 function reveals that function is modulated by phosphorylation in the C-terminal domain. Melly GC; Stokas H; Davidson PM; Roma JS; Rhodes HL; Purdy GE Mol Microbiol; 2021 Feb; 115(2):208-221. PubMed ID: 32985735 [TBL] [Abstract][Full Text] [Related]
32. Biochemical and Structural Characterization of TesA, a Major Thioesterase Required for Outer-Envelope Lipid Biosynthesis in Mycobacterium tuberculosis. Nguyen PC; Nguyen VS; Martin BP; Fourquet P; Camoin L; Spilling CD; Cavalier JF; Cambillau C; Canaan S J Mol Biol; 2018 Dec; 430(24):5120-5136. PubMed ID: 30292819 [TBL] [Abstract][Full Text] [Related]
33. Ester-prodrugs of ethambutol control its antibacterial activity and provide rapid screening for mycobacterial hydrolase activity. Larsen EM; Stephens DC; Clarke NH; Johnson RJ Bioorg Med Chem Lett; 2017 Oct; 27(19):4544-4547. PubMed ID: 28882482 [TBL] [Abstract][Full Text] [Related]
34. Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis. Nguyen PC; Delorme V; Bénarouche A; Guy A; Landry V; Audebert S; Pophillat M; Camoin L; Crauste C; Galano JM; Durand T; Brodin P; Canaan S; Cavalier JF Bioorg Chem; 2018 Dec; 81():414-424. PubMed ID: 30212765 [TBL] [Abstract][Full Text] [Related]
35. Uncovering the Serine Hydrolytic Landscape of Mycobacterium tuberculosis. Boshoff HI Cell Chem Biol; 2016 Feb; 23(2):209-211. PubMed ID: 26971871 [TBL] [Abstract][Full Text] [Related]
36. Sclerotiorin inhibits protein kinase G from Mycobacterium tuberculosis and impairs mycobacterial growth in macrophages. Chen D; Ma S; He L; Yuan P; She Z; Lu Y Tuberculosis (Edinb); 2017 Mar; 103():37-43. PubMed ID: 28237032 [TBL] [Abstract][Full Text] [Related]
37. Metabolic and bactericidal effects of targeted suppression of NadD and NadE enzymes in mycobacteria. Rodionova IA; Schuster BM; Guinn KM; Sorci L; Scott DA; Li X; Kheterpal I; Shoen C; Cynamon M; Locher C; Rubin EJ; Osterman AL mBio; 2014 Feb; 5(1):. PubMed ID: 24549842 [TBL] [Abstract][Full Text] [Related]
39. Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria. Madacki J; Laval F; Grzegorzewicz A; Lemassu A; Záhorszká M; Arand M; McNeil M; Daffé M; Jackson M; Lanéelle MA; Korduláková J J Biol Chem; 2018 Apr; 293(14):5172-5184. PubMed ID: 29472294 [TBL] [Abstract][Full Text] [Related]